CV

Colorcon Ventures

North America, Pennsylvania, United States, Harleysville

Description

Colorcon Ventures is an investment firm that invests in and supports entrepreneurs.

Investor Profile

Colorcon Ventures has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 50% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Medical, Health Care, Therapeutics.

Stage Focus

  • Seed (50%)
  • Series Unknown (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Medical
  • Health Care
  • Therapeutics
  • Biotechnology
  • Business Development
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Colorcon Ventures frequently co-invest with?

SP
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Portal Innovations
North America, Illinois, United States, Chicago
Co-Investments: 1
Bold Capital Partners
North America, California, United States, Santa Monica
Co-Investments: 1
Touchdown Ventures
North America, New Jersey, United States, Haddonfield
Co-Investments: 1

What are some of recent deals done by Colorcon Ventures?

Syntis Bio

Boston, Massachusetts, United States

Syntis Bio operates as a late-stage preclinical company that develops oral therapies for obesity, diabetes, and rare diseases.

Health CareMedicalTherapeutics
Series AJul 1, 2025
Amount Raised: $33,000,000
Vedanta Biosciences

Cambridge, Massachusetts, United States

Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.

BiotechnologyBusiness DevelopmentMedical
Series UnknownFeb 22, 2024
Syntis Bio

Milton, Massachusetts, United States

Syntis Bio operates as a late-stage preclinical company intended to develop a new class of therapy.

Health CareMedicalTherapeutics
SeedJan 17, 2023
Amount Raised: $15,372,179